Kees H.
- Country
- The Netherlands
- Department
- Oncology
Research Overview
Data & Insights
Has run more than one trial at 5 of 21 partner sites.
Specializations
Urologic Oncology
The investigator specializes in the treatment of high-risk non-muscle invasive bladder cancer (NMIBC), with particular focus on cases that have become unresponsive to conventional therapies.
- Bladder Cancer Management
- BCG-Unresponsive Disease
- Novel Therapeutic Approaches
Their research interests center on developing therapeutic solutions for patients whose conditions have failed to respond to standard BCG treatment protocols.
Immunotherapy Research
The investigator focuses on advancing innovative immunotherapeutic treatments, particularly studying the combination of novel biological agents with established therapies.
- Combination Therapy Approaches
- Immunological Response
- Treatment Resistance
Their work explores new therapeutic combinations to enhance treatment outcomes in resistant bladder cancer cases.
Clinical Development
The investigator is involved in evaluating novel therapeutic compounds for bladder cancer treatment, with emphasis on safety assessment and therapeutic efficacy.
- Safety Assessment
- Therapeutic Response
- Disease Monitoring
Their expertise includes the evaluation of treatment responses through various clinical assessment methods including cystoscopy and radiologic imaging.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.